Home / About Spectranetics / Executives

Scott Drake

Scott Drake

Chief Executive Officer

Scott Drake has served as President and Chief Executive Officer of Spectranetics (NASDAQ: SPNC) since 2011. Under Drake’s leadership, revenue grew from $117.9 million in 2010 to $245.9 million in 2015. Drake’s engineering of the 2014 acquisition of AngioScore Inc. and the 2015 acquisition of the Stellarex™ drug-coated balloon platform broadened the company’s portfolio for delivering clinical solutions for complex cardiovascular conditions and paved the way for future growth. Prior to joining Spectranetics, Drake served as Senior Vice President, Operations, of DaVita, Inc. (NYSE: DVA), a leading U.S. provider of kidney care and dialysis. His operations generated more than $6 billion of revenue, or about 20% of DaVita’s total revenue. Previously, Drake spent 17 years in several leadership positions within numerous health care business units at Covidien. From 2006 to 2009, Drake was Global Business Unit President, Respiratory and Monitoring Solutions, a $1.5 billion business with 8,000 employees. Drake was named an EY 2014 Entrepreneur Of The Year™. He is Chairman of the Board of Just Right Surgical and serves on the board of directors for The Spectranetics Corporation, AtriCure (NASDAQ: ATRC), and the Medical Device Manufacturers Association (MDMA). He earned a BS in Business Administration from Miami University of Ohio.
Stacy McMahan

Stacy McMahan

Chief Financial Officer

Stacy McMahan joined Spectranetics in September 2015 as Chief Financial Officer. She previously served as CFO of MSA Safety Incorporated, a global industrial company protecting the health and safety of industrial workers for over 100 years. During her tenure, MSA expanded enterprise value over 18%, strengthened capital access for strategic investments, and refreshed its capital deployment program. In 2014, McMahan led a strategic review for MSA that culminated in expanding inorganic growth goals and a more focused approach to value creation. Previously, she served over twenty years in the life science industry, most recently as Vice President, Finance for the Customer Channels Group of Thermo Fisher Scientific where she directed the channel finance function supporting research, safety and healthcare customers and suppliers. Prior to that role, McMahan served over six years with the Johnson & Johnson family of companies as the Vice President of Finance and CFO for Johnson & Johnson Customer & Logistics Services and Johnson & Johnson Health Care Systems as well as World Wide Vice President of Finance and CFO for DePuy Orthopaedics and Executive Director of Finance for Ethicon Endo-Surgery. Before joining Johnson & Johnson, she progressed through a variety of leadership roles over sixteen years with Eli Lilly and Company, including eight years of international experience in Europe and Australia. She was CFO of Lilly’s global animal health division as well as CFO of Lilly Australia Pty. Ltd. Stacy is a graduate of Oklahoma State University, holds a MBA from the Harvard Business School and is a Certified Management Accountant.
Shahriar(Shar) Matin

Shahriar (Shar) Matin

Chief Operating Officer

Shar Matin has served as Chief Operating Officer of Spectranetics since 2014. Following the closing of AngioScore Inc. in 2014 and Stellarex™ in 2015, Matin became the President of the AngioScore subsidiary and leads Spectranetics’ drug-coated balloon programs. At Spectranetics, Matin started his career as Managing Director of Europe, Russia and the Middle East in 2007. He was promoted to Vice President and Managing Director, International, in 2008. In 2010, He became Senior Vice President of Operations, Product Development and International, and in 2012, he became Senior Vice President of Operations, Business Development and International. Before joining Spectranetics, Matin was the Business Unit Director for Boston Scientific’s cardiac rhythm management operations in China and served in several commercial and engineering roles at Guidant Corporation. Mr. Matin serves on the board of directors of the Fitzsimons Redevelopment Authority in Aurora, Colorado Mr. Matin earned a BS in Mechanical Engineering from the University of California, Berkeley, with honors, and an MBA from Harvard Business School.
Donna Ford-Serbu

Donna Ford-Serbu

Senior VP

Sales & Marketing Lead Management

Donna Ford-Serbu, Senior Vice President, Sales and Marketing, Lead Management, joined Spectranetics as Senior Vice President Global Marketing, Strategy and Portfolio in October 2011. Prior to joining Spectranetics, Ford-Serbu held the position of Vice President, Global Marketing Patient Monitoring at Covidien. In this role she oversaw the global marketing function for the patient monitor business that represents over half of the revenue in Covidien’s Respiratory and Monitoring Solutions division. During her tenure as Vice President, Global Marketing Patient Monitoring, Ford-Serbu drove efforts to transform the business from one focused solely on pulse oximetry to a broad monitoring platform with respiratory function and end organ perfusion monitoring. She led teams to improve the innovation pipeline and served as the integration lead for the $250 million acquisition of Aspect Medical in 2008 and commercial integration lead for the Somanetics acquisition in 2010. These efforts resulted in 32% growth of the patient monitoring business in three years. Prior to her role at Respiratory and Monitoring Solutions, Ford-Serbu spent 10 years at the Energy-based Devices division at Covidien, holding positions of increasing responsibility in the areas of sales and marketing management, business development, and strategy and portfolio across the Electrosurgery, LigaSure and Interventional Oncology business lines. During her time as Business Director for the Interventional Oncology business, Ford-Serbu led the integration of the Vivant Medical acquisition in 2005. Ford-Serbu holds an MBA from the University of Rochester, and a BS from the University of Colorado.
Robert Fuchs

Robert Fuchs

Senior VP

Global Human Resources

Robert Fuchs was named Senior Vice President, Global Human Resources, in January 2014. In this role, Fuchs oversees all aspects of Global Human Resources and leads the company in its mission to “Attract, Retain and Develop the Best Talent on the Planet.” Fuchs has served in numerous human resources leadership positions in the high-tech, telecommunications, mining, and service industries. Prior to joining Spectranetics in October 2012, he was Senior Vice President of Human Resources for EchoStar Communications, a high-tech engineering company with annual revenues of $3 billion. Prior to EchoStar Communications, Fuchs was Vice President of Human Resources for Dish Network, a digital television provider with annual revenues of $12 billion. Fuchs holds a BS in Business Management from Ithaca College, New York.
Paul Gardon

Paul Gardon

Senior VP

General Counsel

Paul Gardon was named Senior Vice President, General Counsel, in January 2014. He has practiced law for over 20 years and is responsible for oversight of all legal matters pertaining to Spectranetics. Prior to joining the organization in early 2012, Gardon served as General Counsel for a business unit of DaVita, a leading provider of kidney care and dialysis services, with revenues in excess of $1 billion. From 2004 to 2010, he held numerous positions of increasing responsibility at Covidien, including Vice President of Legal Affairs for two large divisions. He holds a BS from Marquette University and a JD from the Villanova University School of Law.

Back to top

X